axicabtagene ciloleucel,Tisagenlecleucel
gilead,Novartis,daiichi sankyo
['alycante', 'lysa']
#17icml . alycante trial by dr.houot phase 2 lysa. median age 70. cmr66.1% at 3m. best cmr 82%, ctdna + pet positive both 21%. mefs 12.3m, 52.3%; mpfs 48.8%; m os is nr. 78.3% 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166